Sandra Tribolo

Dr. Sandra Tribolo

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 August 2023 in Journal of Ethnopharmacology
Verified
Journal Article
Open access
JVJustine Verre
Justine Verre
MBMarie Boisson
Marie Boisson
APAnne Paumier
Anne Paumier
STSandra Tribolo
Sandra Tribolo
NBNaoual boujedaini
Naoual boujedaini
The plant Arnica montana L. has been shown to alleviate inflammation, pain and swelling associated with trauma, and post-operative clinical conditions, yet the mechanism of action is not well understood. The study was designed to investigate the effect of Arnica montana (A. montana) mother tincture and homeopathic dilutions on inflammation markers, oxidative stress and cell migration in diverse cell culture models. We tested A. montana mother tincture and a range of homeopathic dilutions in different human and murine cell culture models to demonstrate their anti-inflammatory properties by measuring the inflammatory markers: tumor necrosis factor alpha (TNFα), interleukin-6 (IL-6), cyclooxygenase-2 (COX-2), monocyte chemoattractant protein-1 (MCP-1), intercellular adhesion molecule (ICAM-1) reactive oxygen species (ROS) and cell migration. The inflammatory markers were measured by ELISA assays. The intracellular oxidative stress (ROS) in microglial cells was measured using Deep Red CellROX probe. The cell migration was examined by wound healing using the Oris Cell migration assay. These data showed the ability of A. montana (mother tincture and mainly 1C dilution) to significantly reduce TNFα production in inflamed macrophages compared with vehicle (control). They significantly reduced both IL-6 and MCP-1 in inflamed human microglial cells and significantly decreased COX-2 expression in inflamed murine fibroblasts. Moreover, A. montana mother tincture reduced the cell migration whereas 9C dilution significantly enhanced the migration of fibroblast cells compared with vehicle. The expression of ICAM-1 was significantly reduced with A. montana mother tincture and 1C, 3C, 5C, and 9C dilutions in inflamed human endothelial cells compared with vehicle. A. montana mother tincture and 1C, 3C, 5C and 9C dilutions induced a significant and consistent effect on ROS production in inflamed murine microglial cells. A. montana 1C had the largest impact on ROS production. Mother tincture and 1C dilution of A. montana showed anti-inflammatory properties assessed by measurement of several markers (pro-inflammatory cytokines, adhesion molecule, ROS) in various human and murine cell models. In addition, A. montana 3C, 5C, 9C dilutions have anti-inflammatory and antioxidant effects as highlighted on both primary endothelial cells and murine microglial cells.

1 April 2022 in Dose-Response
Verified
Journal Article
Open access
APAnne Paumier
Anne Paumier
JVJustine Verre
Justine Verre
STSandra Tribolo
Sandra Tribolo
NBNaoual boujedaini
Naoual boujedaini
Microglial cells play important roles in inflammatory responses. The level of oxidative stress is a well-known marker of inflammation. Homeopathic medicines are often used clinically to alleviate inflammation. We evaluated the anti-oxidative effect of high dilutions of Arnica montana (Arnica m.), Arsenicum album (Arsenicum a.), and Lachesis mutus (Lachesis m.) on production of reactive oxygen species (ROS) in inflamed microglial cells in vitro. Microglial cells, on exposure to lipopolysaccharide (LPS), have induced production of ROS compared with resting cells. The dilutions significantly reduced the oxidative stress by decreasing the level of ROS produced. Arnica m. 1C, 3C, 5C, 7C, 9C, and 30C dilutions had a range of ROS reduction between 15 and 42.1%; Arsenicum a. 3C, 5C, 7C, 15C, and 30C dilutions had a range of ROS reduction between 17.6 and 35.3%; and Lachesis m. 3C, 5C, 7C, 9C, 15C, and 30C dilutions had a range of ROS reduction between 25 and 41.7%. To summarize, the dilutions with the greatest effect were Arnica m. 1C (42.1%), Arsenicum a. 30C (35.3%), and Lachesis m. 7C (41.7%). Arnica m., Arsenicum a., and Lachesis m. did not have the same effect on ROS production and were not dose-dependent.

Verified
Journal Article
Open access
PDF file
APAnne PAUMIER
Anne PAUMIER
JVJustine Verre
Justine Verre
GRGael Runel
Gael Runel
JCJULIEN CHLASTA
JULIEN CHLASTA
STSandra Tribolo
Sandra Tribolo
SCStéphanie Chanut
Stéphanie Chanut
Anas barbariae 200K, a homeopathic medicine, is traditionally used for influenza-like illnesses. We investigated the effects of Anas barbariae 200K on microglial cells, a subpopulation of macrophages specific to the central nervous system often used to study the inflammatory processes and oxidative stress generated during influenza-like episodes. The study demonstrates the effect of Anas barbariae 200K on cell stiffness and the reactive oxygen species production using atomic force microscopy and fluorescence microscopy techniques, respectively. Our results showed that Anas barbariae 200K rapidly increased cell stiffness in resting cells by 41% compared with the vehicle. In inflamed cells, cell stiffness was decreased by 21% when treated with Anas barbariae 200K compared with the vehicle. Finally, Anas barbariae 200K caused a reorganisation of filamentous actin, with marked relocation of actin at the cell extremities. Moreover, Anas barbariae 200K significantly decreased the reactive oxygen species (ROS) production in inflamed microglial cells by 40% (total intracellular ROS) and by 67% (mitochondrial ROS) compared with the vehicle. These results strongly suggest an effect of Anas barbariae 200K at a cellular level on cell stiffness and actin cytoskeleton. This sheds light on the biological mechanism of action of this homeopathic preparation.

7 May 2026 in International Journal of High Dilution Research - ISSN 1982-6206
Verified
Journal Article
Open access
PDF file
SDSolène Debasly
Solène Debasly
STSandra Tribolo
Sandra Tribolo
DRDamien Rioult
Damien Rioult
CTChristine Terryn
Christine Terryn
PTPascal TREMPAT
Pascal TREMPAT
CSChristophe Schneider
Christophe Schneider
Background: The immune system is a key component of the tumor microenvironment (TME), which includes endothelial cells, extracellular matrix–producing fibroblasts, and immune cells. Thymulin is involved in immune regulation, notably in the maturation of T lymphocytes, central actors of the adaptive immune response. Several homeopathic medicines are traditionally used to support these immune functions. Objectives: This study aimed to assess the effects of Thymulin 3cH and 9cH on immune components of the TME using an original multicellular spheroid model. Methods: A 3D multicellular spheroid model was established using colorectal cancer cells (HT 29), fibroblasts (Ccd18Co), for testing Peripheral Blood Mononuclear Cells (PBMCs) immune activity isolated from healthy donors. The T lymphocytes were isolated from PBMC using magnetic beads and antibodies to obtain the enriched T lymphocytes. PBMCs were pre-treated with homeopathic dilutions (6% v/v) or undynamised water (control), then activated for 24 hours with anti CD3/anti CD28 antibodies before being added to the spheroids. The metabolite function of T lymphocytes and the clustering were measured using Seahorse® and Incucyte® technologies. Results: Activated T lymphocytes treated with Thymulin 3cH or 9cH formed more clusters than controls and showed an increase of glycolytic activity reflecting an enhanced T-cell functional state. In the spheroid model, both homeopathic dilutions of Thymulin 3cH and 9cH significantly increased apoptosis among spheroid-derived cells, reflecting enhanced caspase activity triggered by PBMCs treated with Thymulin 3cH and 9cH. Conclusion: This model enabled evaluation of the immunomodulatory impact of the homeopathic dilutions on TME-associated immune activity. Thymulin 3cH and 9cH reinforce immune responses by stimulating glycolytic activity and caspase-mediated apoptosis in the multicellular spheroid model.

2 December 2024 in International Journal of High Dilution Research - ISSN 1982-6206
Verified
Journal Article
Open access
PDF file
MBMarie Boisson
Marie Boisson
JVJustine Verre
Justine Verre
APAnne Paumier
Anne Paumier
STSandra Tribolo
Sandra Tribolo
SCStéphanie Chanut
Stéphanie Chanut
Background: Some homeopathic medicines are traditionally used in medical practice to strengthen immunity and reduce inflammation. In particular, Influenzinum is used in clinical practice for the prevention of influenza-like illness, the management of possible symptoms following an anti-influenza vaccination and post-infectious convalescence. Echinacea angustifolia is the best known for its beneficial effects on the immune system and infectious syndrome. During an infection (viral or bacterial), the innate immunity is the first body response. It is an immediate inflammatory reaction which involves, among other factors, phagocytosis and oxidative stress at the cellular level (1). Objectives: To evaluate in vitro the effect of homeopathic dilutions of Influenzinum 9CH and 15CH and Echinacea angustifolia 5CH on biological markers of cellular inflammation and phagocytosis in several cellular models. Results: In inflamed macrophages, Influenzinum 9CH significantly increases the production of IL-6 (Interleukin-6) and MCP-1 (Monocyte Chemoattractant Protein-1) by 26% and 34%, respectively, compared with placebo which help to eliminate pathogens. In inflamed endothelial cells, Influenzinum 9CH and 15CH significatly decrease ICAM-1(InterCellular Adhesion Molecule-1) production by 20% compared with placebo, limiting the vascular inflammation. Furthermore, Influenzinum 9CH and 15CH demonstrated an antioxidant effects by significantly decreasing total ROS (reactive oxygen species) in inflamed primary microglia cells. Moreover, Echinacea angustifolia 5CH significantly increases the phagocytosis by 15% in monocytes and 25% in microglial cells compared with water (placebo) in non-inflammatory conditions. Conclusions: We demonstrated that Influenzinum and Echinacea angustifolia have a biological action in cell models in vitro. In inflammatory conditions, Influenzinum 9CH and 15CH have (i) immunostimulant effect, (ii) anti-inflammlatory effect on vascular cells, (iii) antioxidant effect. Echinacea angustifolia 5CH stimulates phagocytosis. Overall, Influenzinum and Echinacea angustifolia have a boosting effect on various biological parameters of innate immunity.